Mario Gabelli Crispr Therapeutics Ag Transaction History

Gamco Investors, Inc. Et Al

  • $9 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
BUY
$61.1 - $83.78 $244,400 - $335,120
4,000 New
4,000 $261,000
Q3 2021

Nov 12, 2021
SELL
$110.2 - $156.64 $341,620 - $485,583
-3,100 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$100.84 - $161.89 $312,604 - $501,858
3,100 New
3,100 $502,000

Others Institutions Holding CRSP

# of Institutions
485
Shares Held
57.5M
Call Options Held
1.09M
Put Options Held
1.9M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.12B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track Mario Gabelli's Portfolio

Track Mario Gabelli Portfolio

Follow Mario Gabelli (Gamco Investors, Inc. Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email